On July 26, at the Novokramatorsk Machine-Building Plant, voluntary vaccination of the company's personnel against coronavirus began. Within a week, the first thousand of NKMZ employees will receive the first injection out of two.
“Vaccination of employees is on schedule. Only on July 27, 185 factory workers received the first dose of Moderna vaccine, ”the press service of NKMZ says.
For vaccination, a two-phase vaccine against COVID-19 of American production Moderna is used. It was developed by the National Institute of Allergy and Infectious Diseases (USA). According to the results of large-scale clinical trials and use in various countries around the world, the safety of Moderna has been proven in practice. Its efficiency is 94.1%.
In total, the enterprise has five vaccination locations: in the Central Factory Laboratory, a medical unit, household premises of MX No. 12 and two in the engineering building. Also, for the vaccination of former employees of the enterprise, one location was created in the DK and T NKMZ. For them, vaccination will begin on 30.07.2021.
Medical teams - employees of the city health department - vaccinate factory workers and fill out the relevant documents. After the procedure, here, the health of each vaccinated person is monitored, and when the second dose of vaccination is administered after 28 days, all vaccinated will be given a personal certificate of international standard.
If among those who want to get vaccinated there are employees of the enterprise who have not yet concluded a declaration with a family doctor, they must come for vaccination with a passport of a citizen of Ukraine, personal identification number and a mobile phone. This is necessary in order to conclude such a declaration here.